CAS: 1132709-14-8
((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid
CAS:1132709-14-8
Formula:
C19H25BN4O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
384.2372
Ref: IN-DA008W3I
| 10mg | 143.00 € | ||
| 25mg | 204.00 € | ||
| 50mg | 457.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-B-4675
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
(1S,2S)-Bortezomib-d5
Controlled ProductCAS:1132709-14-8
Formula:
C19D5H20BN4O4
Color and Shape:
Neat
Molecular weight:
389.268
Ref: TR-B675717
| 25mg | 9,045.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
(1S,2S)-Bortezomib
Controlled ProductCAS:1132709-14-8
Impurity Bortezomib USP Impurity G Stability Hygroscopic Applications (1S,2S)-Bortezomib is an isomer of Bortezomib (B675700), …
Formula:
C19H25BN4O4
Color and Shape:
Neat
Molecular weight:
384.24
Ref: TR-B675715
| 1mg | 334.00 € | ||
| 10mg | 2,248.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
(1S,2S)-Bortezomib
CAS:1132709-14-8
(1S,2S)-Bortezomib (Bortezomib) is an enantiomer of Bortezomib.
Formula:
C19H25BN4O4
Purity:
98.33%
Color and Shape:
Solid
Molecular weight:
384.24
Ref: TM-T10061
| 1mg | 63.00 € | ||
| 2mg | 95.00 € | ||
| 5mg | 166.00 € | ||
| 10mg | 278.00 € | ||
| 25mg | 445.00 € | ||
| 50mg | 604.00 € | ||
| 100mg | 811.00 € | ||
| 1mL*10mM (DMSO) | 171.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025
(1S,2S)-Bortezomib
CAS:1132709-14-8
Versatile small molecule scaffold
Formula:
C19H25BN4O4
Purity:
Min. 95%
Molecular weight:
384.24 g/mol
Ref: 3D-HVB70914
| 1mg | Discontinued | Request information | |
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
